Carbapenemase Gene Transmission in CREC: Lessons from Guangdong

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) pose a mounting threat to global healthcare, with Enterobacter cloacae complex (CREC) ranking among the leading culprits in nosocomial infections. The COVID-19 pandemic further exacerbated antibiotic use and altered infection control practices, raising concerns about accelerated resistance emergence. However, data on the molecular epidemiology and precise transmission dynamics of carbapenemase-encoding genes (CEGs) in CREC—especially during and after the pandemic—remain limited. The recent study by Chen et al. (2025) addresses these gaps by characterizing CEGs and their mobility in CREC isolates across eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024.

Key Innovation from the Reference Study

The most significant advancement presented by Chen et al. is the in-depth delineation of CEG carriage on both chromosomal and plasmid DNA within CREC isolates, coupled with a rigorous assessment of the genes' horizontal and vertical transmission capacities. The study not only quantifies the prevalence of key resistance genes (notably blaNDM-1, blaIMP, and blaKPC-2) but also systematically evaluates their transferability and genetic contexts. By integrating plasmid elimination, conjugation assays, and genotyping, the work provides a high-resolution map of multidrug resistance transmission routes during a critical epidemiological period.

Methods and Experimental Design Insights

Chen et al. adopted a multi-pronged experimental approach. Fifty-four non-redundant CREC isolates were collected from eight geographically and institutionally diverse hospitals. The study employed:

• Variable temperature SDS plasmid elimination to distinguish between chromosomal and plasmid-borne resistance determinants.
• PCR-based detection for identifying blaNDM-1, blaIMP, and blaKPC-2 genes and mapping their genomic locations.
• Broth microdilution for phenotypic antibiotic susceptibility profiling, focusing on both carbapenems and other clinically relevant agents.
• Plasmid conjugation experiments to measure the rates and efficiency of horizontal gene transfer.
• ERIC-PCR and NTSYS cluster analysis for genotyping and tracking epidemiological relatedness among isolates.
• Characterization of mobile genetic elements (MGEs) to contextualize the genetic vehicles enabling gene mobility, with particular attention to ISEcp1 and other insertion sequences.

This robust design enables precise assignment of resistance determinants to their genetic contexts, while also elucidating the clinical and demographic factors associated with CEG prevalence.

Protocol Parameters

• Isolate selection: Non-redundant CREC from multiple clinical departments and sample sources (e.g., sputum, urine).
• Plasmid elimination: Variable temperature SDS treatment, ensuring effective curing of plasmids for differentiation studies.
• PCR amplification: Gene-specific primers targeting blaNDM-1, blaIMP, blaKPC-2; confirmation of chromosomal vs plasmid localization through cured strains.
• Broth microdilution: Standardized MIC testing for a panel of antibiotics, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Conjugation assay: Mating of donor CREC with recipient strains, selection of transconjugants on antibiotic-supplemented media, and PCR confirmation of transferred CEGs.
• Genotyping: ERIC-PCR fingerprinting and cluster analysis using NTSYS software to define clonal relationships.
• MGE screening: PCR and sequencing for detection of insertion sequences (e.g., ISEcp1) and other MGEs linked to CEG mobility.

Core Findings and Why They Matter

The study revealed that 85.2% of CREC isolates harbored carbapenemase-encoding genes. Notably, blaNDM-1 was the most frequently detected, residing on both chromosomes and plasmids in 33.3% and exclusively on plasmids in 46.3% of isolates. A minor fraction carried blaIMP or combined blaNDM-1 and blaKPC-2. The high positive rate underscores the dominance of mobile genetic elements in resistance dissemination. Conjugation experiments demonstrated a 95.7% success rate in transferring CEGs, confirming the substantial capacity for horizontal gene transfer within and potentially between species. Six types of MGEs were identified, with ISEcp1 present in 87% of strains. Most notably, strains harboring multiple CEGs and MGEs exhibited elevated multidrug resistance rates, particularly to carbapenems and other frontline antibiotics.

Demographically, the study found higher detection frequencies of CEG-positive CREC in males (64.8%), elderly patients (72.2%), respiratory medicine departments (20.4%), and sputum samples (33.3%). Genotyping further revealed 17 distinct CREC types, with some clones distributed across multiple hospitals and departments, suggesting both localized outbreaks and inter-facility transmission. These findings highlight both the clinical risks and the epidemiological complexity of controlling CREC in tertiary care settings.

Comparison with Existing Internal Articles

Several internal articles, including "Ertapenem Sodium Salt: Optimizing Resistance Assays in CREC" and "Ertapenem Sodium Salt: Mechanism, Efficacy, and Resistance Insights", have previously outlined the use of Ertapenem sodium salt as a benchmark antibacterial agent for Gram-positive and Gram-negative bacteria in resistance profiling. These resources focus on methodological best practices, including protocol enhancements for resistance detection and troubleshooting of susceptibility assays, which align with the reference study’s use of broth microdilution and conjugation-based resistance tracking. However, the Chen et al. study uniquely integrates epidemiological mapping, molecular genotyping, and detailed MGE analysis, providing a broader context for resistance monitoring workflows discussed in the internal articles. By bridging molecular epidemiology with practical assay optimization, the reference paper complements and extends the technical recommendations found in these internal resources.

Limitations and Transferability

While the study delivers an unprecedented snapshot of CEG prevalence and mobility in Guangdong hospitals, some limitations warrant consideration. The isolate collection, though multi-institutional, is geographically bounded and temporally linked to the COVID-19 pandemic period. This may influence the generalizability of findings to other regions or timeframes. Furthermore, while the plasmid elimination and conjugation protocols are rigorous, not all possible CEGs or MGEs may have been detected due to primer specificity or methodological constraints. Nevertheless, the overall workflow—including delineation of chromosomal versus plasmid localization and integration of genotyping—remains highly transferable to similar clinical and research settings, especially for institutions seeking to monitor multidrug resistance dynamics in real-time.

Research Support Resources

To facilitate advanced resistance profiling and transmission studies in CREC or similar organisms, researchers can employ validated reagents such as Ertapenem (sodium salt) (SKU C3451), a broad-spectrum carbapenem antibiotic with well-characterized pharmacokinetics and robust activity against both Gram-positive and Gram-negative bacteria. As summarized in the internal literature, this compound is valuable for setting up MIC assays, benchmarking resistance, and troubleshooting multidrug resistance workflows. APExBIO offers this product for research use only, supporting the type of molecular and phenotypic investigations detailed above. For detailed workflows and troubleshooting strategies, related internal resources further distill best practices for resistance assay design and data interpretation.